Skip to main content
logo
China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.400
-0.035 (-1.44%)
At close: Sep 18, 2026, 4:00 PM EDT
2.350
-0.050 (-2.08%)
After-hours: Sep 18, 2026, 7:47 PM EDT

China SXT Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Net Income
0.16-6.37-2.5-0.86.6-9.7-4.44-1.49-2.64-3.09
Depreciation & Amortization
0.110.030.080.070.10.10.140.110.130.19
Other Amortization
--0.430.090.080.210.020.310.03-
Loss (Gain) From Sale of Assets
--0.01-------
Asset Writedown & Restructuring Costs
----0.42-0.35---
Stock-Based Compensation
-0.375.67--0.35-0.280.282.010.33
Provision & Write-off of Bad Debts
0.26-0.130.26--8.178.452.88-1.02-0.54
Other Operating Activities
-1.030.030.950.03-0.040.040.07-0.94-
Change in Accounts Receivable
0.190.10.05-0.3-0.25-0.071.29-0.370.130.7
Change in Inventory
0.15-0.660.45-0.75-0.15-0.040.130.280.270.03
Change in Accounts Payable
-0.05-0.65-0.440.33-0.050.02-0.240.25-0.030.01
Change in Income Taxes
0.03-0.01-0.020.010-0-0.010.03-0.040
Change in Other Net Operating Assets
-1.720.23-0.25-0.03-0.250.4100.05-1.242.07
Operating Cash Flow
-2.26-1.75-0.99-1.36-1.35-0.580.47-0.550.58-0.31
Operating Cash Flow Growth (YoY)
-------19.34%---

Investing Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Capital Expenditures
---0--0.01--0.05-0.02-0.04-0.02
Sale of Property, Plant & Equipment
--0.020.04------
Sale (Purchase) of Intangibles
-1.25---------
Investment in Securities
--------9.28-9.28
Other Investing Activities
0.92-0.92--0.010.02-00.060.02-
Investing Cash Flow
-0.33-0.920.020.040.010.02-0.050.049.26-9.3

Financing Activities

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Short-Term Debt Issued
---7.01------
Long-Term Debt Issued
-0.31-0.37-0.12----
Total Debt Issued
0.210.310.317.381.370.124.03-2.8-
Short-Term Debt Repaid
------4.58--11.06--3.89
Long-Term Debt Repaid
--0.12--0.08--0--0.01--0.02
Total Debt Repaid
-0.26-0.12-1.84-0.080.58-4.598.22-11.070.06-3.91
Net Debt Issued (Repaid)
-0.050.19-1.537.31.95-4.4612.25-11.072.87-3.91
Issuance of Common Stock
9.115.182.76---2.19-3.12-
Other Financing Activities
---0.07-0.07-0.11--0.43--0.48-
Financing Cash Flow
9.065.371.167.241.84-4.4614.01-11.075.5-3.91

Net Cash Flow

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Foreign Exchange Rate Adjustments
0.510.37-0.580.520.12-0.88-0.04-1.010.20.2
Net Cash Flow
6.983.07-0.386.440.61-5.914.39-12.5915.54-13.33

Free Cash Flow

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Free Cash Flow
-2.26-1.75-0.99-1.36-1.36-0.580.42-0.570.54-0.33
Free Cash Flow Growth (YoY)
-------22.53%---
Free Cash Flow Margin
-442.81%-279.71%-108.64%-163.62%-137.07%-61.68%54.73%-47.11%34.25%-32.45%
Free Cash Flow Per Share
--------0.27-0.02
Levered Free Cash Flow
-4.46-0.27-1.49-1.084.35-5.585.18-3.395.5-3.19
Unlevered Free Cash Flow
-4.44-0.25-1.63-1.054.41-5.585.21-3.475.5-3.19

Additional Metrics

Fiscal Quarter
H2 2026H1 2026H2 2025H1 2025H2 2024H1 2024H2 2023H1 2023H2 2022H1 2022
Period Ending
Mar '26 Sep '25 Mar '25 Sep '24 Mar '24 Sep '23 Mar '23 Sep '22 Mar '22 Sep '21
Cash Interest Paid
0.010.01-0.020.020.010.01-0-
Cash Income Tax Paid
--------00.02
Change in Working Capital
-1.4-0.99-0.23-0.75-0.70.321.170.25-0.912.81
SEC Filings: 10-K · 10-Q